Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Chong Kun Dang Pharmaceutical)"
Count: 292
Selected: 0
NCT IDTitle
NCT05050604A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate in Vascular Cognitive Impairment Patients
NCT05041790A Clinical Trial to Evaluate the Efficacy and Safety of Choline Alfoscerate Compared to Placebo in Patients With Degenerative Mild Cognitive Impairment
NCT06399068Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fed Conditions
NCT06399055Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-387 in Healthy Volunteers Under Fasting Conditions
NCT06386328A Clinical Trial to Evaluate the Food Effect of CKD-378
NCT06281132Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D956 in Healthy Adults
NCT06204107A Clinical Trial to Evaluate the Food Effect on Pharmacokinetic Profiles and Safety of CKD-379
NCT06121518Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy Versus D064 or D702 Monotherapy
NCT06112678A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(6)
NCT06110923A Clinical Trial to Compare and Evaluate Evaluate the Pharmacokinetics and Safety of CKD-846
NCT06088017A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391(2)
NCT06044493MYREPTIC-N® or MY-REPT® in Stable Patients After Kidney Transplant Recipients
NCT05952219Study to Evaluate the Safety and Pharmacokinetics of CKD-379
NCT05931224Clinical Trial to Evaluate the Efficacy and Safety of D064 and D702 Combination Therapy
NCT05928637A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of D745, D759, and D150
NCT05921435Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetic After Oral Administration of CKD-341 and D958 in Healthy Adults
NCT05897216Evaluate the Pharmacokinetics and Safety Between the Treatment of CKD-383 and Treatment of CKD-501, D745, D150, and D029
NCT05881707A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg
NCT05881213Clinical Trial to Investigate the Pharmacokinetics and Safety After Oral Administration of CKD-378 and Co-administration of D745, D150, D029 in Healthy Adults
NCT05843162A Clinical Trial to Evaluate the Blood Pressure Control of Telmisartan or Losartan in Essential Hypertensive Patients With Metabolic Syndrome
NCT05834595A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828
NCT05816759Evaluate the Pharmacokinetics and Safety Between the Administration of CKD-383 and the Co-administration of CKD-501, D744, and D150
NCT05749861A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(5)
NCT05741437A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-378
NCT05719155Pharmacokinetics and Safety/Tolerability of CKD-379
NCT05698043A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(5) 80/20/10mg
NCT05677438A Phase 2 Study to Evaluate the Safety and Efficacy of CKD-498 in Female Patients With Androgenetic Alopecia
NCT05673369Clinical Study to Evaluate Pharmacokinetic Profiles and Safety of CKD-387 Under Fasting Condition
NCT05657574A Clinical Trial to Evaluate the Efficacy and Safety of CKD-391 and CKD-331 in Patients With Primary Hypercholesterolemia
NCT05634447A Clinical Trial to Compare and Evaluate the Safety and Pharmacokinetics of CKD-391
NCT05587699The Parallel Study to Evaluate the Pharmacokinetics, Pharmacodynamics, and Safety of CKD-843 A
NCT05571813Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-341 in Healthy Subjects
NCT05566028The Efficacy and Safety of D745 Added to D150 Plus D759 Therapy in Patients With Type 2 Diabetes
NCT05552495Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-386 in Healthy Volunteers Under Fasting Conditions
NCT05549401Clinical Trial to Evaluate the Tolerability and the Pharmacokinetics of CKD-348
NCT05544214Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD 371 in Healthy Subjects
NCT05540912Exploratory Trial to Evaluate the Pharmacokinetic Properties and Safety of CKD-828 in Healthy Subjects
NCT05526742A Study to Evaluate the Relative Bioavailability of Formulations of CKD-510 and to Assess the Effect of Food on the CKD-510 Tablet Formulation in Healthy Subjects
NCT05526703Clinical Trial to Evaluate the Efficacy and Safety of D064 and D701 Combination Therapy
NCT05452525Pharmacokinetics and Safety/Tolerability Profile of CKD-379
NCT05347576A Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393(2) in Healthy Volunteers Under Fed Conditions
NCT05335044Study to Evaluate the Safety and Pharmacokinetics of CKD-331
NCT05274880Study to Evaluate the Food Effect on Pharmacokinetics Profile and Safety of CKD-393
NCT05245084A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-386(3) 80/20/10mg
NCT05238948CKD-506 Drug-Drug Interaction Study in Healthy Male Subjects
NCT05207761Study to Evaluate Drug-drug Interaction, Safety and Tolerability in Case of the Co-administration of D565 and D930
NCT05193565Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients
NCT05192356A Clinical Trial to Evaluate the Tolerability and Pharmacokinetics of CKD-348(3)
NCT05189288Clinical Study to Evaluate the Pharmacokinetics, Safety and Tolerability of CKD-388(2) in Healthy Subjects
NCT05113693Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-393